177 related articles for article (PubMed ID: 33166606)
1. Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis.
Hargrove D; Liang B; Kashfi-Sadabad R; Joshi GN; Gonzalez-Fajardo L; Glass S; Jay M; Salner A; Lu X
J Control Release; 2020 Dec; 328():846-858. PubMed ID: 33166606
[TBL] [Abstract][Full Text] [Related]
2. Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery.
Fu Q; Hargrove D; Lu X
Nanomedicine; 2016 Oct; 12(7):1951-1959. PubMed ID: 27151564
[TBL] [Abstract][Full Text] [Related]
3. Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer.
Wang S; Wo L; Zhang Z; Zhu C; Wang C; Wang Y; Hou L; Cao H; Zhao Q; Zhao E
Cancer Lett; 2022 Nov; 549():215916. PubMed ID: 36126899
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors.
Dai Q; Wilhelm S; Ding D; Syed AM; Sindhwani S; Zhang Y; Chen YY; MacMillan P; Chan WCW
ACS Nano; 2018 Aug; 12(8):8423-8435. PubMed ID: 30016073
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
6. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
7. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
[TBL] [Abstract][Full Text] [Related]
8. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
[TBL] [Abstract][Full Text] [Related]
9. Janus Mesoporous Silica Nanoparticles for Dual Targeting of Tumor Cells and Mitochondria.
López V; Villegas MR; Rodríguez V; Villaverde G; Lozano D; Baeza A; Vallet-Regí M
ACS Appl Mater Interfaces; 2017 Aug; 9(32):26697-26706. PubMed ID: 28759196
[TBL] [Abstract][Full Text] [Related]
10. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.
Samykutty A; Grizzle WE; Fouts BL; McNally MW; Chuong P; Thomas A; Chiba A; Otali D; Woloszynska A; Said N; Frederick PJ; Jasinski J; Liu J; McNally LR
Biomaterials; 2018 Nov; 182():114-126. PubMed ID: 30118979
[TBL] [Abstract][Full Text] [Related]
11. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
[TBL] [Abstract][Full Text] [Related]
14. Serum Protein Adsorption Enhances Active Leukemia Stem Cell Targeting of Mesoporous Silica Nanoparticles.
Beck M; Mandal T; Buske C; Lindén M
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18566-18574. PubMed ID: 28525262
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
[No Abstract] [Full Text] [Related]
16. Folic Acid-Polyethyleneimine Functionalized Mesoporous Silica Nanoparticles as a Controlled Release Nanocarrier.
Park J; Park SS; Jo NJ; Ha CS
J Nanosci Nanotechnol; 2019 Oct; 19(10):6217-6224. PubMed ID: 31026940
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.
Colby AH; Oberlies NH; Pearce CJ; Herrera VL; Colson YL; Grinstaff MW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 28185434
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides.
Simón-Gracia L; Hunt H; Teesalu T
Molecules; 2018 May; 23(5):. PubMed ID: 29772690
[TBL] [Abstract][Full Text] [Related]
19. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-based nanoparticles for cancer targeting.
Sá LT; Simmons S; Missailidis S; da Silva MI; Santos-Oliveira R
J Drug Target; 2013 May; 21(5):427-34. PubMed ID: 23350808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
